CN114246817A - Wrinkle-removing composition and preparation method and application thereof - Google Patents
Wrinkle-removing composition and preparation method and application thereof Download PDFInfo
- Publication number
- CN114246817A CN114246817A CN202210060301.8A CN202210060301A CN114246817A CN 114246817 A CN114246817 A CN 114246817A CN 202210060301 A CN202210060301 A CN 202210060301A CN 114246817 A CN114246817 A CN 114246817A
- Authority
- CN
- China
- Prior art keywords
- parts
- wrinkle
- phase component
- stirring
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 134
- 238000002360 preparation method Methods 0.000 title claims abstract description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 65
- 230000001153 anti-wrinkle effect Effects 0.000 claims abstract description 43
- 230000037303 wrinkles Effects 0.000 claims abstract description 42
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 25
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 22
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 22
- YDSVPIYLRFZLAT-UHFFFAOYSA-N C(C)(=O)O.C(C)(=O)O.NC(CCC(=O)NCC1=CC=CC=C1)N Chemical compound C(C)(=O)O.C(C)(=O)O.NC(CCC(=O)NCC1=CC=CC=C1)N YDSVPIYLRFZLAT-UHFFFAOYSA-N 0.000 claims abstract description 21
- 108010016626 Dipeptides Proteins 0.000 claims abstract description 21
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 claims abstract description 16
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 claims abstract description 16
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 239000012071 phase Substances 0.000 claims description 66
- 238000003756 stirring Methods 0.000 claims description 59
- 239000003921 oil Substances 0.000 claims description 49
- 235000019198 oils Nutrition 0.000 claims description 49
- 239000000284 extract Substances 0.000 claims description 46
- 238000002156 mixing Methods 0.000 claims description 38
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 32
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 22
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 22
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 22
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 21
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 21
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 21
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 20
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 20
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 18
- 230000000694 effects Effects 0.000 claims description 18
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 16
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 16
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 claims description 16
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 16
- 229940057910 shea butter Drugs 0.000 claims description 16
- 229940032094 squalane Drugs 0.000 claims description 16
- 239000002738 chelating agent Substances 0.000 claims description 15
- 239000003906 humectant Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 239000003974 emollient agent Substances 0.000 claims description 13
- 244000125300 Argania sideroxylon Species 0.000 claims description 12
- 239000008367 deionised water Substances 0.000 claims description 12
- 229910021641 deionized water Inorganic materials 0.000 claims description 12
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 11
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 11
- 229920002125 Sokalan® Polymers 0.000 claims description 11
- 239000003963 antioxidant agent Substances 0.000 claims description 11
- 230000003078 antioxidant effect Effects 0.000 claims description 11
- 229960001631 carbomer Drugs 0.000 claims description 11
- 239000003995 emulsifying agent Substances 0.000 claims description 11
- 239000002562 thickening agent Substances 0.000 claims description 11
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 claims description 10
- 239000008346 aqueous phase Substances 0.000 claims description 9
- 229940074410 trehalose Drugs 0.000 claims description 8
- 235000016108 Argania sideroxylon Nutrition 0.000 claims description 6
- 235000019488 nut oil Nutrition 0.000 claims description 6
- 239000010466 nut oil Substances 0.000 claims description 6
- 229940042585 tocopherol acetate Drugs 0.000 claims description 6
- 229940083957 1,2-butanediol Drugs 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 5
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 5
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 claims description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 5
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims description 5
- 239000003002 pH adjusting agent Substances 0.000 claims description 5
- 244000144725 Amygdalus communis Species 0.000 claims description 4
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 4
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 4
- 239000009636 Huang Qi Substances 0.000 claims description 4
- 244000042664 Matricaria chamomilla Species 0.000 claims description 4
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 4
- 235000007164 Oryza sativa Nutrition 0.000 claims description 4
- 240000001341 Reynoutria japonica Species 0.000 claims description 4
- 235000018167 Reynoutria japonica Nutrition 0.000 claims description 4
- 229940059958 centella asiatica extract Drugs 0.000 claims description 4
- 239000002537 cosmetic Substances 0.000 claims description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 4
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 235000009566 rice Nutrition 0.000 claims description 4
- 229940092665 tea leaf extract Drugs 0.000 claims description 4
- RJZNPROJTJSYLC-LLINQDLYSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O RJZNPROJTJSYLC-LLINQDLYSA-N 0.000 claims description 3
- 239000004909 Moisturizer Substances 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 3
- 230000001333 moisturizer Effects 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 claims description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 2
- 108010024636 Glutathione Proteins 0.000 claims description 2
- 244000086363 Pterocarpus indicus Species 0.000 claims description 2
- 235000009984 Pterocarpus indicus Nutrition 0.000 claims description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 229960003180 glutathione Drugs 0.000 claims description 2
- 229940075529 glyceryl stearate Drugs 0.000 claims description 2
- 229940102253 isopropanolamine Drugs 0.000 claims description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 2
- 235000013824 polyphenols Nutrition 0.000 claims description 2
- 229920000053 polysorbate 80 Polymers 0.000 claims description 2
- 235000020748 rosemary extract Nutrition 0.000 claims description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 2
- -1 tea leaf extract Substances 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 230000002829 reductive effect Effects 0.000 abstract description 11
- 230000014759 maintenance of location Effects 0.000 abstract description 10
- 102000016942 Elastin Human genes 0.000 abstract description 7
- 108010014258 Elastin Proteins 0.000 abstract description 7
- 230000019522 cellular metabolic process Effects 0.000 abstract description 7
- 229920002549 elastin Polymers 0.000 abstract description 7
- 210000002950 fibroblast Anatomy 0.000 abstract description 7
- 230000002401 inhibitory effect Effects 0.000 abstract description 7
- 230000004118 muscle contraction Effects 0.000 abstract description 7
- 230000035755 proliferation Effects 0.000 abstract description 7
- 210000003491 skin Anatomy 0.000 description 87
- 229940060184 oil ingredients Drugs 0.000 description 33
- 238000012360 testing method Methods 0.000 description 26
- 230000000052 comparative effect Effects 0.000 description 12
- 230000037394 skin elasticity Effects 0.000 description 12
- 230000003020 moisturizing effect Effects 0.000 description 11
- 238000001816 cooling Methods 0.000 description 9
- 210000000434 stratum corneum Anatomy 0.000 description 8
- 230000008859 change Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 230000009044 synergistic interaction Effects 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- 241001632409 Aralia elata Species 0.000 description 3
- 235000015888 Aralia elata Nutrition 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010040914 Skin reaction Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000035483 skin reaction Effects 0.000 description 3
- 231100000430 skin reaction Toxicity 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000011076 safety test Methods 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 description 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 244000042430 Rhodiola rosea Species 0.000 description 1
- 235000003713 Rhodiola rosea Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000010478 argan oil Substances 0.000 description 1
- 235000019206 astragalus extract Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 229940105902 mint extract Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000037331 wrinkle reduction Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
The invention provides a wrinkle-removing composition and a preparation method and application thereof, wherein the preparation raw materials of the wrinkle-removing composition comprise an efficacy component, a water phase component and an oil phase combination, and the efficacy component comprises acetyl hexapeptide-8, dipeptide diaminobutyryl benzylamide diacetate, anti-wrinkle peptide for tightening face and oat beta-glucan. The wrinkle-removing composition provided by the invention firstly promotes the proliferation of fibroblasts, improves the metabolism of cells, promotes the expression of elastin and improves the softness of skin; the moisture retention and the tightening smoothness of the skin are improved by renewing and repairing the tense skin; finally, the generation of wrinkles is reduced by inhibiting muscle contraction; thereby tightening the eye skin in all directions and lightening the wrinkles of the eyes.
Description
Technical Field
The invention belongs to the field of cosmetic preparation, and particularly relates to a wrinkle-removing composition as well as a preparation method and application thereof.
Background
The skin is the largest organ of the human body, and the eye skin is the thinnest part of the skin and is very fragile. After the skin is aged or injured by the external environment, the skin of the eyes is dry and thin, and the collagen of the dermis layer is continuously reduced, so that the reticular supporting force is lost, and various eye problems such as wrinkles, fishtail lines and the like appear on the skin. With the continuous improvement of the living standard of people at present, the requirements of people on skin care are also continuously improved, and people pay more and more attention to eye skin care. The existing products on the market achieve the effect of removing wrinkles by mainly adding a film-forming agent, a filling agent, an expression line inhibitor, a collagen fiber repairing agent and the like.
CN105943475A discloses an anti-wrinkle eye cream containing traditional Chinese medicine components and a preparation method and application thereof, wherein the anti-wrinkle eye cream comprises glycerol, methyl glucoside eicosoxy-ethylene, stearic acid, a silicon smoothing agent, hyaluronic acid, isomerized sugar, rose essential oil, an astragalus extract, an acanthopanax extract, a rhodiola rosea extract, a gynostemma pentaphylla extract and a lithospermum extract. The anti-wrinkle eye cream provided by the invention is fresh, cool, smooth, mild and non-irritant, can maintain moisture of eye skin for a long time, promotes blood circulation of eyes, effectively reduces fine wrinkles of the eyes, but cannot repair the generated fine wrinkles.
CN110897898A discloses an anti-wrinkle moisturizing eye patch and a preparation method thereof, wherein the anti-wrinkle moisturizing eye patch comprises eye patch liquid, and the eye patch liquid is composed of 1.5-4.5 parts by weight of ginseng extract, 1-3 parts by weight of retinol, 3-7 parts by weight of resveratrol, 1.5-4.5 parts by weight of jellyfish extract, 1.5-4.5 parts by weight of citrus extract, 1-3 parts by weight of arbutin, 3-7 parts by weight of papain, 0.5-1.5 parts by weight of polypeptide-1, 1-3 parts by weight of trehalose, 3-7 parts by weight of orange extract, 3-7 parts by weight of green tea pearl powder, 1.5-4.5 parts by weight of mint extract, 1-3 parts by weight of cubilose extract, 1-3 parts by weight of scutellaria root extract and 1.5-4.5 parts by weight of propolis. The eye patch liquid of the anti-wrinkle moisturizing eye patch has good permeability and is easy to absorb, and the eye patch is endowed with anti-wrinkle and moisturizing effects; but the anti-wrinkle moisturizing eye mask provided by the invention has slow effect.
Therefore, how to provide a wrinkle-removing composition with good wrinkle-removing effect and quick response becomes a problem to be solved at present.
Disclosure of Invention
Aiming at the defects of the prior art, the invention aims to provide a wrinkle-removing composition and a preparation method and application thereof. The wrinkle-removing composition provided by the invention firstly promotes the proliferation of fibroblasts, improves the metabolism of cells, promotes the expression of elastin and improves the softness of skin; the moisture retention and the tightening smoothness of the skin are improved by renewing and repairing the tense skin; finally, the generation of wrinkles is reduced by inhibiting muscle contraction; thereby tightening the eye skin in all directions and lightening the wrinkles of the eyes.
In order to achieve the purpose, the invention adopts the following technical scheme:
in a first aspect, the invention provides a wrinkle-removing composition prepared from raw materials comprising an efficacy component, an aqueous phase component and an oil phase combination, wherein the efficacy component comprises acetyl hexapeptide-8, dipeptide diaminobutyryl benzylamide diacetate, anti-wrinkle and oat beta-glucan.
In the invention, acetyl hexapeptide-8, dipeptide diaminobutyrylbenzylamide diacetate, tight face wrinkle resistant peptide and oat beta-glucan are mutually matched for synergistic interaction; firstly, the expression of elastin is promoted and the softness of skin is improved by promoting the proliferation of fibroblasts and improving the metabolism of cells; the moisture retention and the tightening smoothness of the skin are improved by renewing and repairing the tense skin; finally, the generation of wrinkles is reduced by inhibiting muscle contraction; thereby tightening the eye skin in all directions and lightening the wrinkles of the eyes.
In the invention, the weight ratio of the combination of the efficacy component, the water phase component and the oil phase is (5-24): (65-93): (4.5-24), and can be, for example, 5:65:4.5, 7:70:6, 9:73:8, 11:75:10, 13:82:12, 15:88:14, 17:90:16, 19:91:18, 21:92:20, 23:93:22, 24:89:24 and the like. Preferably, the efficacy components comprise the following components in parts by weight: acetyl hexapeptide-81-5 parts, dipeptide diaminobutyrylbenzylamide diacetate 1-5 parts, tight face wrinkle resistant peptide 1-4 parts and oat beta-glucan 1-5 parts.
In the present invention, the acetyl hexapeptide-8 is present in an amount of 1 to 5 parts by weight, for example, 1 part, 2 parts, 3 parts, 4 parts, 5 parts, etc.
In the present invention, the dipeptide diaminobutyrylbenzylamide diacetate is 1 to 5 parts by weight, for example, 1 part, 2 parts, 3 parts, 4 parts, 5 parts, and the like.
In the present invention, the weight portion of the tight face anti-wrinkle peptide is 1-4 parts, for example, 1 part, 2 parts, 3 parts, 4 parts, etc.
In the present invention, the oat β -glucan is 1 to 5 parts by weight, and may be 1 part, 2 parts, 3 parts, 4 parts, 5 parts, or the like, for example.
According to the invention, firstly, the anti-wrinkle peptide for tightening the face promotes the proliferation of fibroblasts, improves the cell metabolism, promotes the synthesis of collagen, improves the softness of the skin, repairs the visual signs of aging and provides a long-term skin lifting effect; through the excellent transdermal absorption performance of the oat beta-glucan, the moisture retention of the skin is quickly improved, the roughness is reduced, the synthesis of various collagens is promoted, the tense skin is renewed and repaired, and the moisture retention and the tightening smoothness of the skin are improved; finally, the acetyl hexapeptide-8 and the dipeptide diaminobutyrylbenzylamide diacetate can reduce the generation of wrinkles at different sites by inhibiting muscle contraction; the acetyl hexapeptide-8, the dipeptide diaminobutyryl benzylamide diacetate, the anti-wrinkle tightening peptide and the oat beta-glucan are matched with each other, have synergistic effect, tighten the eye skin in an all-round way and lighten the wrinkles of the eyes.
Preferably, the anti-wrinkle and anti-wrinkle peptide comprises sweet almond seed extract and hydrolyzed rice protein.
Preferably, the weight ratio of the sweet almond seed extract to the hydrolyzed rice protein is (1.5-2.5):1, and may be, for example, 1.5:1, 1.6:1, 1.7:1, 1.8:1, 1.9:1, 2.0:1, 2.1:1, 2.2:1, 2.3:1, 2.4:1, 2.5:1, and the like.
Preferably, the efficacy component further comprises ON-mediline.
Preferably, the ON-mediline is present in 1-5 parts by weight, and may be, for example, 1 part, 2 parts, 3 parts, 4 parts, 5 parts, etc.
Preferably, the ON-mediline comprises centella asiatica extract, polygonum cuspidatum root extract, astragalus membranaceus root extract, tea leaf extract, glycyrrhiza glabra root extract, chamomile flower extract, and rosmarinus officinalis extract.
In the invention, the ON-MEDI LINE is a compound plant anti-allergy agent extracted from seven plants, and can relieve skin and reduce anaphylactic reaction.
Preferably, the weight ratio of the centella asiatica extract, the polygonum cuspidatum root extract, the astragalus membranaceus root extract, the tea leaf extract, the glycyrrhiza glabra root extract, the chamomile flower extract and the rosewood extract is 1 (0.5-1.5): 0.5-1.5: (0.5-1.5), for example, 1:0.5:0.5:0.5:0.5:0.5: 0.7:0.7:0.7:0.7:0.7: 1:1:1:1: 1.1:1.1:1.1:1.1: 1.9: 0.9: 1.1.1: 1.5:1.5:1.5:1.5: 1.7: 1.1.1: 1.1.5: 1.5:1.5: 1.5.
In the present invention, the aqueous phase component includes a humectant, a coffee extract, and water.
Preferably, the water phase component comprises 1-7 parts by weight of humectant, 0.1-1 part by weight of coffee extract and 65-85 parts by weight of water.
In the present invention, the humectant is 1 to 7 parts by weight, and may be, for example, 1 part, 2 parts, 3 parts, 4 parts, 5 parts, 6 parts, 7 parts, or the like.
In the present invention, the coffee extract may be present in an amount of 0.1 to 1 part by weight, for example, 0.1 part, 0.2 part, 0.3 part, 0.4 part, 0.5 part, 0.6 part, 0.7 part, 0.8 part, 0.9 part, 1 part, etc.
In the present invention, the amount of the water is 65 to 85 parts by weight, and examples thereof include 65 parts, 67 parts, 69 parts, 71 parts, 73 parts, 75 parts, 77 parts, 79 parts, 81 parts, 83 parts, and 85 parts.
Preferably, the humectant comprises any one or a combination of at least two of trehalose, sodium hyaluronate, 1, 2-hexanediol or butanediol, preferably a combination of trehalose, sodium hyaluronate, 1, 2-hexanediol and butanediol.
In the invention, the trehalose, the sodium hyaluronate, the 1, 2-hexanediol and the butanediol are mutually matched, have synergistic interaction, build a three-dimensional retention system of skin and jointly improve the moisturizing performance of the anti-wrinkle composition. Improving the skin state and increasing the firmness and smoothness of the skin.
Preferably, the weight ratio of trehalose, sodium hyaluronate, 1, 2-hexanediol and butanediol is (0.2-2): (0.02-0.2): (0.1-0.5): (1-4), and may be, for example, 0.2:0.02:0.5:1, 0.4:0.04:0.4:1.5, 0.6:0.06:0.3:2, 0.8:0.08:0.2:2.5, 1.0:0.10:0.1:2.9, 1.2:0.12:0.1:3.2, 1.4:0.14:0.1:3.4, 1.6:0.16:0.1:3.6, 1.8:0.18:0.1:3.8, 2.0:0.20:0.1:4, etc.
Preferably, the molecular weight of the sodium hyaluronate is 1000-3000 kDa.
Preferably, the water comprises deionized water.
Preferably, the aqueous phase component further comprises a thickener.
Preferably, the thickener is present in an amount of 0.2 to 0.6 parts by weight, and may be, for example, 0.2 parts, 0.3 parts, 0.4 parts, 0.5 parts, 0.6 parts, etc.
Preferably, the thickener comprises any one or a combination of at least two of carbomer, sodium carboxymethylcellulose or xanthan gum, preferably carbomer.
In the present invention, the oil phase component includes an emollient and an emulsifier.
Preferably, the oil phase component comprises 2-13 parts of an emollient and 1-5 parts of an emulsifier in parts by weight.
In the present invention, the weight part of the emollient is 2 to 13 parts, and may be, for example, 2 parts, 3 parts, 4 parts, 5 parts, 6 parts, 7 parts, 8 parts, 9 parts, 10 parts, 11 parts, 12 parts, 13 parts, etc.
In the present invention, the emulsifier is 1 to 5 parts by weight, for example, 1 part, 2 parts, 3 parts, 4 parts, 5 parts, etc.
Preferably, the emollient comprises any one or a combination of at least two of dioctyl carbonate, squalane, argan nut oil, or shea butter, preferably a combination of dioctyl carbonate, squalane, argan nut oil, and shea butter.
In the invention, dioctyl carbonate, squalane, argan tree kernel oil and shea butter are matched with each other, so that the synergy is realized, a skin barrier is built, the skin is deeply nourished, and the skin becomes soft and elastic; the permeability is increased, so that various components in the anti-wrinkle composition are more easily absorbed by the skin.
Preferably, the weight ratio of the dioctyl carbonate, the squalane, the argan tree kernel oil and the shea butter is (1-5): (0.1-1): (0.5-2), and can be 1:1:0.1:0.5, 2:2:0.3:1.0, 3:3:0.5:1.3, 4:4:0.7:1.7, 5:5:1:2 and the like.
Preferably, the emulsifier comprises any one or a combination of at least two of Simulsol 165, PolyAquol 2W or TWEEN 80, preferably PolyAquol 2W.
Preferably, the PolyAquol 2W includes polyglyceryl-2 stearate, glyceryl stearate, and stearic acid.
Preferably, the oil phase component further comprises an antioxidant.
Preferably, the antioxidant is present in an amount of 0.1 to 1 part by weight, and may be, for example, 0.1 part, 0.2 part, 0.3 part, 0.4 part, 0.5 part, 0.6 part, 0.7 part, 0.8 part, 0.9 part, 1 part, etc.
Preferably, the antioxidant comprises any one or a combination of at least two of tocopheryl acetate, tea polyphenols or glutathione, preferably tocopheryl acetate.
In the present invention, tocopheryl acetate can be used in combination with other components to improve the antioxidant capacity of the wrinkle-reducing composition.
In the invention, the raw materials for preparing the wrinkle-removing composition also comprise a pH regulator.
Preferably, the pH adjuster is 0.06-0.25 parts by weight, and may be, for example, 0.06 parts, 0.08 parts, 0.1 parts, 0.12 parts, 0.14 parts, 0.16 parts, 0.19 parts, 0.2 parts, 0.22 parts, 0.25 parts, etc.
Preferably, the pH adjusting agent comprises any one or a combination of at least two of aminomethyl propanol, triethanolamine or isopropanolamine, preferably aminomethyl propanol.
In the present invention, since the thickener carbomer in the aqueous phase component is acidic, a pH adjusting agent is required for neutralization.
Preferably, the raw materials for preparing the wrinkle-removing composition also comprise a chelating agent.
Preferably, the chelating agent comprises caprylhydroxamic acid and/or disodium edetate, preferably caprylhydroxamic acid.
As a preferred technical scheme, the wrinkle-removing composition comprises preparation raw materials, an efficacy component, a water phase component, an oil phase component, a pH regulator and a chelating agent;
wherein the functional components comprise the following components in parts by weight: 1-5 parts of oat beta-glucan, 81-5 parts of acetyl hexapeptide, 1-5 parts of dipeptide diaminobutyryl benzylamide diacetate, 1-4 parts of tight face and anti-wrinkle peptide and 1-5 parts of ON-MEDI LINE;
the water phase components comprise the following components in parts by weight: 0.2-2 parts of trehalose, 0.02-0.1 part of sodium hyaluronate, 0.1-0.5 part of 1, 2-hexanediol, 1-4 parts of butanediol, 0.1-1 part of coffee extract, 0.2-0.6 part of carbomer and 65-85 parts of deionized water;
the oil phase comprises the following components in parts by weight: 1-5 parts of dioctyl carbonate, 1-5 parts of squalane, 0.1-1 part of argania spinosa kernel oil, 0.5-2 parts of shea butter, 1-5 parts of Polyaquol 2W and 0.1-1 part of tocopherol acetate;
the pH regulator comprises the following components in parts by weight: 0.06-0.25 part of aminomethyl propanol, wherein the chelating agent comprises the following components in parts by weight: 0.01-0.3 part of caprylyl hydroximic acid.
As a further preferable technical scheme, the wrinkle-removing composition comprises preparation raw materials, an efficacy component, a water phase component, an oil phase component, a pH regulator and a chelating agent;
wherein the functional components comprise the following components in parts by weight: 2-3 parts of oat beta-glucan, 82-4 parts of acetyl hexapeptide, 1-2 parts of dipeptide diaminobutyryl benzylamide diacetate, 1-2 parts of tight face and anti-wrinkle peptide and 1-2 parts of ON-MEDI LINE;
the water phase components comprise the following components in parts by weight: 0.5-1.5 parts of trehalose, 0.02-0.05 part of sodium hyaluronate, 0.3-0.5 part of 1, 2-hexanediol, 1.5-4 parts of butanediol, 0.1-0.5 part of coffee extract, 0.3-0.5 part of carbomer and 68-83 parts of deionized water;
the oil phase comprises the following components in parts by weight: 2-4 parts of dioctyl carbonate, 1-3 parts of squalane, 0.3-1 part of argania spinosa kernel oil, 0.8-2 parts of shea butter, 1-3 parts of Polyaquol 2W and 0.2-1 part of tocopherol acetate;
the pH regulator comprises the following components in parts by weight: 0.15-0.2 part of aminomethyl propanol, wherein the chelating agent comprises the following components in parts by weight: 0.01-0.2 part of caprylyl hydroximic acid.
In a second aspect, the present invention provides a method of preparing a wrinkle-reducing composition as defined in the first aspect, the method comprising the steps of: and mixing the functional components containing acetyl hexapeptide-8, dipeptide diaminobutyrylbenzyl amide diacetate and face-tightening anti-wrinkle peptide, the water phase component and the oil phase component, and stirring to obtain the wrinkle-removing composition.
Preferably, the preparation method of the aqueous phase component comprises the following steps: mixing humectant, coffee extract, optional thickener and deionized water, and stirring to obtain water phase component; the humectant comprises any one or a combination of at least two of trehalose, sodium hyaluronate or butanediol.
Preferably, in the preparation method of the aqueous phase component, the stirring temperature is 75-85 deg.C, such as 75 deg.C, 76 deg.C, 77 deg.C, 78 deg.C, 79 deg.C, 80 deg.C, 81 deg.C, 82 deg.C, 83 deg.C, 84 deg.C, 85; the time is 10-15min, such as 10min, 11min, 12min, 13min, 14min, 15min, etc.
Preferably, the preparation method of the oil phase component comprises the following steps: mixing emollient, emulsifier and optional antioxidant, and stirring to obtain the oil phase component.
Preferably, in the preparation method of the oil phase component, the stirring temperature is 75-85 deg.C, such as 75 deg.C, 76 deg.C, 77 deg.C, 78 deg.C, 79 deg.C, 80 deg.C, 81 deg.C, 82 deg.C, 83 deg.C, 84 deg.C, 85; the time is 10-15min, such as 10min, 11min, 12min, 13min, 14min, 15min, etc.
In the present invention, the wrinkle-removing composition is prepared by a method comprising the steps of:
(a) mixing the water phase component and the oil phase component, stirring and homogenizing to obtain a mixture 1;
(b) mixing a pH regulator with the mixture 1 obtained in the step (a), and stirring to obtain a mixture 2;
(c) mixing a chelating agent, optionally 1, 2-hexanediol, and the mixture 2 obtained in step (b), and stirring to obtain a mixture 3;
(d) mixing the functional components with the mixture 3 obtained in the step (c), and stirring to obtain the wrinkle-removing composition.
Preferably, in step (a), the stirring temperature is 75-85 ℃, for example, 75 ℃, 76 ℃, 77 ℃, 78 ℃, 79 ℃, 80 ℃, 81 ℃, 82 ℃, 83 ℃, 84 ℃, 85; the time is 5-10min, such as 5min, 6min, 7min, 8min, 9min, 10min, etc.
Preferably, in step (b), the stirring temperature is 60-65 ℃, for example, 60 ℃, 61 ℃, 62 ℃, 63 ℃, 64 ℃, 65 ℃ and the like; the time is 5-10min, such as 5min, 6min, 7min, 8min, 9min, 10min, etc.
Preferably, in step (c), the stirring temperature is 50-55 deg.C, such as 50 deg.C, 51 deg.C, 52 deg.C, 53 deg.C, 54 deg.C, 55 deg.C; the time is 5-10min, such as 5min, 6min, 7min, 8min, 9min, 10min, etc.
Preferably, in the step (d), the stirring temperature is 25-40 ℃, for example, 25 ℃, 27 ℃, 29 ℃, 31 ℃, 33 ℃, 35 ℃, 37 ℃, 40 ℃ and the like; the time is 10-15min, such as 10min, 11min, 12min, 13min, 14min, 15min, etc.
As a preferred technical scheme of the invention, the preparation method of the wrinkle-removing composition comprises the following steps:
(1) mixing humectant, coffee extract, optional thickener and deionized water, stirring at 75-85 deg.C for 10-15min to obtain water phase component, wherein the humectant comprises one or more of trehalose, sodium hyaluronate or butanediol; mixing emollient, emulsifier and optional antioxidant, and stirring at 75-85 deg.C for 10-15min to obtain oil phase component;
(2) mixing the water phase component and the oil phase component obtained in the step (1), stirring for 5-10min at 75-85 ℃, and homogenizing to obtain a mixture 1;
(3) mixing a pH regulator with the mixture 1 obtained in the step (2), and stirring at 60-65 ℃ for 5-10min to obtain a mixture 2;
(4) mixing a chelating agent, optional 1, 2-hexanediol and the mixture 2 obtained in the step (3), and stirring at 50-55 ℃ for 5-10min to obtain a mixture 3;
(5) and (4) mixing the functional components with the mixture 3 obtained in the step (4), and stirring for 10-15min at 25-40 ℃ to obtain the wrinkle-removing composition.
In a third aspect, the present invention provides a use of the wrinkle-removing composition according to the first aspect in the preparation of a cosmetic for wrinkle-removing and tightening eyes.
Compared with the prior art, the invention has the following beneficial effects:
(1) the wrinkle-removing composition provided by the invention firstly promotes the proliferation of fibroblasts, improves the metabolism of cells, promotes the expression of elastin and improves the softness of skin; the moisture retention and the tightening smoothness of the skin are improved by renewing and repairing the tense skin; finally, the generation of wrinkles is reduced by inhibiting muscle contraction; therefore, the eye skin can be tightened in all directions, and the wrinkles of the eyes can be reduced;
(2) the wrinkle-removing composition provided by the invention can increase the elasticity of the skin by supplementing the moisture of the skin and constructing a moisture loss barrier, so that the skin is more young, and the effects of supplementing water and resisting wrinkles are achieved;
(3) the wrinkle-removing composition provided by the invention has a good free radical removing effect, and the excellent oxidation resistance can reduce the generation of static wrinkles.
Detailed Description
The technical solution of the present invention is further explained by the following embodiments. It should be understood by those skilled in the art that the examples are only for the understanding of the present invention and should not be construed as the specific limitations of the present invention.
The component sources in the following examples are as follows:
example 1
The embodiment provides a wrinkle-removing composition, which comprises the following raw materials in parts by weight:
the preparation method of the wrinkle-removing composition comprises the following steps:
(1) putting deionized water into a water bath, slowly adding carbomer, trehalose, sodium hyaluronate, butanediol and coffee extract, and stirring at 80 deg.C for 15min to obtain water phase component; sequentially adding PolyAquol 2W, dioctyl carbonate, squalane, Aralia mandshurica kernel oil, shea butter and tocopherol acetate into an oil pan, and stirring for 15min at 80 ℃ to obtain the oil phase component;
(2) mixing the water phase component and the oil phase component obtained in the step (1), stirring for 5min at 80 ℃, and homogenizing to obtain a mixture 1;
(3) cooling the mixture 1 obtained in the step (2) to 63 ℃, mixing the aminomethyl propanol with the mixture 1, and stirring at 63 ℃ for 8min to obtain a mixture 2;
(4) cooling the mixture 2 obtained in the step (3) to 53 ℃, mixing the caprylyl hydroximic acid, the 1, 2-hexanediol and the mixture 2, and stirring for 8min at 53 ℃ to obtain a mixture 3;
(5) cooling mixture 3 to 35 deg.C, mixing oat beta-glucan, fobotox, snawring, tightening anti-wrinkle peptide, ON-MEDI LINE and mixture 3, and stirring at 35 deg.C for 15min to obtain the wrinkle-removing composition.
Example 2
The embodiment provides a wrinkle-removing composition, which comprises the following raw materials in parts by weight:
the preparation method of the wrinkle-removing composition comprises the following steps:
(1) putting deionized water into a water bath kettle, slowly adding carbomer, trehalose, sodium hyaluronate, butanediol and coffee extract, and stirring at 81 deg.C for 15min to obtain water phase component; sequentially adding PolyAquol 2W, dioctyl carbonate, squalane, Aralia mandshurica kernel oil, shea butter and tocopherol acetate into an oil pan, and stirring for 15min at 81 ℃ to obtain the oil phase component;
(2) mixing the water phase component and the oil phase component obtained in the step (1), stirring for 5min at 81 ℃, and homogenizing to obtain a mixture 1;
(3) cooling the mixture 1 obtained in the step (2) to 64 ℃, mixing the aminomethyl propanol with the mixture 1, and stirring at 64 ℃ for 5min to obtain a mixture 2;
(4) cooling the mixture 2 obtained in the step (3) to 54 ℃, mixing the caprylyl hydroximic acid, the 1, 2-hexanediol and the mixture 2, and stirring for 5min at 54 ℃ to obtain a mixture 3;
(5) cooling mixture 3 to 37 deg.C, mixing oat beta-glucan, fobotox, snawring, tight-face anti-wrinkle peptide, ON-MEDI LINE and mixture 3, and stirring at 37 deg.C for 15min to obtain the anti-wrinkle composition.
Example 3
The embodiment provides a wrinkle-removing composition, which comprises the following raw materials in parts by weight:
the preparation method of the wrinkle-removing composition comprises the following steps:
(1) putting deionized water into a water bath, slowly adding carbomer, trehalose, sodium hyaluronate, butanediol and coffee extract, and stirring at 82 deg.C for 15min to obtain water phase component; sequentially adding PolyAquol 2W, dioctyl carbonate, squalane, Aralia mandshurica kernel oil, shea butter and tocopherol acetate into an oil pan, and stirring for 15min at 82 ℃ to obtain the oil phase component;
(2) mixing the water phase component and the oil phase component obtained in the step (1), stirring for 5min at 82 ℃, and homogenizing to obtain a mixture 1;
(3) cooling the mixture 1 obtained in the step (2) to 62 ℃, mixing the aminomethyl propanol with the mixture 1, and stirring at 62 ℃ for 8min to obtain a mixture 2;
(4) cooling the mixture 2 obtained in the step (3) to 52 ℃, mixing the caprylhydroxamic acid and the 1, 2-hexanediol with the mixture 2, and stirring for 9min at 52 ℃ to obtain a mixture 3;
(5) cooling the mixture 3 to 30 deg.C, mixing oat beta-glucan, fobotox, snawring, tight-face anti-wrinkle peptide, ON-MEDI LINE and the mixture 3, and stirring at 30 deg.C for 13min to obtain the anti-wrinkle composition.
Example 4
This example provides a wrinkle-reducing composition differing from example 1 only in the absence of ON-mediline, the other components and the method of preparation being the same as in example 1.
Examples 5 to 8
Examples 5-8 provide 4 wrinkle-removing compositions differing from example 1 only in the absence of any of trehalose, sodium hyaluronate, butylene glycol or 1, 2-hexanediol, respectively, and the other components and methods of preparation are the same as example 1.
Example 9
This example provides 1 wrinkle-removing composition, differing from example 1 only in the absence of coffee extract, other components and preparation method as in example 1.
Examples 10 to 13
Examples 10-13 provide 4 wrinkle-removing compositions differing from example 1 only in the absence of any of dioctyl carbonate, squalane, argan nut oil or shea butter, the other components and methods of preparation being the same as in example 1.
Comparative examples 1 to 4
Comparative examples 1-4 provide 4 wrinkle-removing compositions differing from example 1 only in the absence of oat β -glucan, acetyl hexapeptide-8, dipeptide diaminobutyrylbenzylamide diacetate, anti-wrinkle peptide, or an illustration of any one thereof, respectively, and other components and methods of preparation the same as example 1.
Test example 1
Eye skin stratum corneum water content test
Testing a sample: wrinkle-removing compositions provided in examples 1 to 13 and comparative examples 1 to 4
510 skin-healthy 18-40-year-old volunteers, half-in-proportion each, were selected and randomly divided into 17 groups of 15 men and 15 women, and the wrinkle-removing compositions provided in application examples 1 to 13 and comparative examples 1 to 4 were used, respectively. After cleaning the face, the volunteers apply the wrinkle-removing composition on the eye skin, continuously use for 30 days, and measure the moisture content of the stratum corneum before and after use by a skin tester (MC750, CK in Germany);
the water content of the eye skin cuticle of each subject is respectively tested before use and after 30 days of continuous use, each data is tested for three times, after an average value is obtained, the average value of each group is calculated, one digit after a decimal point is reserved, and the change rate of the water content of the skin is calculated according to the following formula:
eye skin stratum corneum moisture change rate (eye skin stratum corneum moisture content 30 days after use-eye skin stratum corneum moisture content before use)/eye skin stratum corneum moisture content before use;
the test results are shown in table 1:
TABLE 1
As can be seen from the data in table 1, the skin moisture content change rate is 5.1-10.2% after 4 hours using the wrinkle-removing composition provided by the present invention (examples 1-13), and 9.2-10.2% after 4 hours using the wrinkle-removing composition provided by the preferred embodiment of the present invention (examples 1-3).
The stratum corneum of the skin contains two types of water, namely bound water and free water, the water content can influence the formation of water and a grease film in the stratum corneum, and the grease film can prevent the excessive evaporation of the water and soften the skin, and has important significance for resisting aging and removing wrinkles of the skin. As can be seen from Table 1, the water content of the horny layer of the eye skin is obviously improved by using the wrinkle-removing composition provided by the invention, and the effect is superior to that of comparative examples 1-4, which shows that the water content of the eye skin can be synergistically improved and the water loss of the skin can be reduced by adjusting the proportion of each component through the compound use of each component.
As can be seen from a comparison of example 1 and example 4, the moisturizing performance of the anti-wrinkle composition is slightly lower in the absence of ON-MEDI LINE, which is an extract of seven plants, in combination with other components, and improves the skin condition.
As can be seen from the comparison between example 1 and examples 5-8, trehalose, sodium hyaluronate, butanediol and 1, 2-hexanediol are matched with each other to achieve synergistic interaction, so that a three-dimensional retention system of skin is built, and the moisturizing performance of the anti-wrinkle composition is improved. The three components are matched with each other, so that the moisture can be supplemented in time, and the loss of the moisture can be reduced.
As can be seen by comparing example 1 with example 9, the absence of coffee extract reduces the moisturizing properties of the wrinkle-removing composition.
As can be seen from the comparison between example 1 and examples 10 to 13, dioctyl carbonate, squalane, argan nut oil and shea butter cooperate with each other to synergistically enhance the effects of building a skin barrier and deeply nourishing the skin, so that the skin becomes soft and elastic; the permeability is increased, so that various components in the anti-wrinkle composition are more easily absorbed by the skin.
The comparison between the example 1 and the comparative examples 1 to 4 shows that the lack of any one of acetyl hexapeptide-8, dipeptide diaminobutyryl benzylamide diacetate, tight wrinkle resistant peptide or oat beta-glucan can reduce the moisturizing effect of the anti-wrinkle composition, and the acetyl hexapeptide-8, the dipeptide diaminobutyryl benzylamide diacetate, the tight wrinkle resistant peptide and the oat beta-glucan are matched with each other to realize synergistic effect, so that the skin moisture can be supplemented, the protective effect is enhanced from the inner skin bottom layer, the moisture loss barrier is effectively improved, the skin elasticity is increased, the skin is younger, and the moisturizing and anti-wrinkle effect is achieved.
Test example 2
Ocular skin elasticity test
Testing a sample: wrinkle-removing compositions provided in examples 1 to 13 and comparative examples 1 to 4
The test method comprises the following steps: selecting 510 volunteers with skin health of 18-40 years old, wherein the proportion of men and women accounts for half respectively, randomly dividing into 17 groups, each group comprises 15 men and 15 women, cleaning the face of the volunteer in the morning and evening each day, smearing wrinkle-removing composition on the skin of the eyes, continuously using for 3 months, and measuring the elasticity of the skin of the eyes by a skin tester (MC750, Germany CK); each data is tested for three times, after the average value is obtained, the average value of each group is calculated, two digits after the decimal point are reserved, and the skin elasticity change rate is calculated according to the following formula:
skin elasticity variation value-skin elasticity parameter 3 months after use-skin elasticity parameter before use
The test results are shown in table 2:
TABLE 2
As can be seen from the data in Table 2, the wrinkle-removing compositions provided by the present invention (examples 1 to 13) exhibited a change in the skin elasticity parameter of 0.05 to 0.09 after 3 months of use; with the wrinkle-removing composition provided in the preferred embodiment of the present invention (examples 1 to 3), the variation value of the skin elasticity parameter after 3 months of use is 0.08 to 0.09.
The greater the value of the skin elasticity parameter, the better the skin elasticity. As can be seen from Table 2, after the wrinkle-removing eye cream prepared by the invention is used by volunteers, the skin elasticity parameter is obviously improved, and the effect is obviously superior to that of comparative examples 1-4, which shows that the wrinkle-removing eye cream can increase the firmness and elasticity of eye skin and improve the skin elasticity.
As can be seen from a comparison of example 1 and example 4, in the absence of ON-MEDI LINE, the effect of increasing skin elasticity is less.
As can be seen from a comparison of example 1 and examples 5-8, the absence of any of trehalose, sodium hyaluronate, butylene glycol or 1, 2-hexanediol in the moisturizer also reduces elastin expression, impairing the effectiveness of the wrinkle-removing composition; this is because the functional components and the moisturizer can cooperate with each other to improve the skin condition and increase the firmness and smoothness of the skin.
As can be seen from a comparison of example 1 and example 9, the effect of the wrinkle-removing composition is impaired in the absence of the coffee extract.
As can be seen by comparing example 1 with examples 10-13, the absence of any of dioctyl carbonate, squalane, argan oil, or shea butter in the absence of an emollient attenuates the effectiveness of the wrinkle-reducing composition because the benefit component and emollient cooperate to increase the firmness and elasticity of the ocular skin and increase skin elasticity.
As can be seen from a comparison of example 1 and comparative examples 1-4, the effect is poor when any one of acetyl hexapeptide-8, dipeptide diaminobutyrylbenzylamide diacetate, anti-wrinkle peptide or oat beta-glucan is absent; the anti-wrinkle composition provided by the invention is characterized in that acetyl hexapeptide-8, dipeptide diaminobutyrylbenzylamide diacetate, tight face anti-wrinkle peptide and oat beta-glucan are matched with each other to realize synergistic interaction; firstly, the expression of elastin is promoted and the softness of skin is improved by promoting the proliferation of fibroblasts and improving the metabolism of cells; the moisture retention and the tightening smoothness of the skin are improved by renewing and repairing the tense skin; finally, the generation of wrinkles is reduced by inhibiting muscle contraction; thereby tightening the eye skin in all directions and lightening the wrinkles of the eyes.
Test example 3
Skin wrinkle reduction test
Testing a sample: wrinkle-removing compositions provided in examples 1 to 13 and comparative examples 1 to 4
The test method comprises the following steps: selecting 510 volunteers with healthy skin and 18-40 years old, wherein the proportion of the volunteers accounts for half of that of men and women, randomly dividing the volunteers into 17 groups, and each group comprises 15 males and 15 females; the eyes of the volunteers have fine lines or wrinkles of certain parts are obvious, and the volunteers apply the wrinkle-removing eye cream prepared by the invention on the skin of the eyes after cleaning the face in the morning and at night every day and continuously use for 6 months. Wrinkle removal test wrinkles in the corners of the eyes of a subject are tested using a multifunctional 3D skin image analyzer (Antera 3D) from Ireland MIRAVEX to obtain a 3D image of the surface structure of the skin in the corners of the eyes, and wrinkle-related data, such as wrinkle depth, volume, area, length, etc., are used to determine, by means of systematic statistical analysis, a parameter of wrinkles in the corners of the eyes, the value ranging from 0 to 100, with a larger value representing fewer wrinkles, finer wrinkles, and shallower wrinkles, with better results.
The testing process comprises the following steps: the tested area is the corner of the face. Prior to testing, subjects uniformly cleansed their face and blotted dry with a dry non-dusting absorbent paper towel. Sit still for 30min in a laboratory at a temperature of 20 + -1 deg.C, 50 + -10% RH. The subject remained relaxed, face exposed, avoiding touch. The laboratory technician tests the subject' S eye and corner wrinkle parameters S1 and then instructs the subject to use the product once in the morning and once in the evening, each time in an amount of about half a coin size, during which time no other skin care product is used. After 6 months, the subject visits again, cleans the face with the facial cleanser, and dries the skin with a dry facial tissue, sits still for 30min in a laboratory at a temperature of 21 ± 1 ℃ and 50 ± 10% RH, and the laboratory technician tests the subject' S canthus wrinkle parameters S2; each data was tested three times, and after averaging, the difference between the average value before use and the average value after 6 months of use of the product was calculated for each group of subjects, and then the wrinkle-removing effect of the product was analyzed using the difference. The rate of change of skin moisture content is calculated according to the following formula:
the change value of the eye corner wrinkles is 6 months after use as the parameter S2 of the eye corner wrinkles and before use as the parameter S1 of the eye corner wrinkles
The test results are shown in table 3:
TABLE 3
The data in table 3 show that the wrinkle-removing composition prepared by the invention has good wrinkle-removing effect, can supplement moisture of skin, increase the firmness and elasticity of eye skin, improve the elasticity of skin, and is beneficial to removing fine lines of eyes, enabling the eye skin to be firm and fine and reducing wrinkles.
In the invention, the efficacy component, the water phase component and the oil phase component are cooperated with each other, thereby achieving good wrinkle removing effect.
As can be seen from comparison of example 1 with comparative examples 1 to 4, the wrinkle-removing effect is poor when any one of acetyl hexapeptide-8, dipeptide diaminobutyrylbenzylamide diacetate, anti-wrinkle peptide or oat beta-glucan is absent; the anti-wrinkle composition provided by the invention is characterized in that acetyl hexapeptide-8, dipeptide diaminobutyrylbenzylamide diacetate, tight face anti-wrinkle peptide and oat beta-glucan are matched with each other to realize synergistic interaction; firstly, the expression of elastin is promoted and the softness of skin is improved by promoting the proliferation of fibroblasts and improving the metabolism of cells; the moisture retention and the tightening smoothness of the skin are improved by renewing and repairing the tense skin; finally, the generation of wrinkles is reduced by inhibiting muscle contraction; thereby tightening skin in all directions and eliminating wrinkles.
Test example 4
Safety test
Testing a sample: wrinkle-removing compositions provided in examples 1 to 13 and comparative examples 1 to 4
The test method comprises the following steps: the adverse reaction test of human skin is carried out by referring to the relevant requirements of 'the test of skin spots on human skin' in the 'cosmetic hygiene Specification' (2007 edition). 510 healthy 18-40 year old volunteers were selected, half the proportion of men and women, and randomly divided into 17 groups of 15 men and 15 women, and no other skin care products were used during the test. Selecting a spot tester with an area of 6mm multiplied by 6mm, putting a test object into a small chamber of the spot tester, wherein the dosage is 0.025g, sticking the spot tester with the test object on the back of a subject by using a hypoallergenic adhesive tape, and lightly pressing the spot tester with a palm to uniformly stick the spot tester on the skin for 24 hours. The skin reaction is observed after 30min (after the indentation disappears), 1h, 2h and 24h after the test object spot tester is removed. The observation results were recorded as shown in "Classification Standard Table for adverse skin reactions" in Table 4, and the safety test results are shown in Table 5.
TABLE 4
| Grade of rating | Skin reactions |
| 0 | Negative reaction |
| 1 | Suspicious reaction, only faint erythema |
| 2 | Erythema, infiltrates, edema, and possibly pimples |
| 3 | Erythema, infiltration, edema, pimples, dragons; the reaction can exceed the tested area |
| 4 | Obvious erythema, severe infiltration, edema, and fusional herpes; reaction beyond the variation zone |
The test results are shown in table 5:
TABLE 5
As can be seen from the data in Table 5, the anti-wrinkle composition provided by the invention is safe and non-irritant.
The applicant states that the invention is illustrated by the above examples to a wrinkle-removing composition of the invention and its preparation method and use, but the invention is not limited to the above examples, i.e. it does not mean that the invention must be practiced by means of the above examples. It should be understood by those skilled in the art that any modification of the present invention, equivalent substitutions of the raw materials of the product of the present invention, addition of auxiliary components, selection of specific modes, etc., are within the scope and disclosure of the present invention.
Claims (10)
1. The wrinkle-removing composition is characterized by being prepared from an effect component, a water phase component and an oil phase, wherein the effect component comprises acetyl hexapeptide-8, dipeptide diaminobutyryl benzylamide diacetate, tightening anti-wrinkle peptide and oat beta-glucan.
2. The wrinkle-removing composition as claimed in claim 1, wherein the weight ratio of the combination of the efficacy component, the water phase component and the oil phase is (5-24): (65-93): (4.5-24);
preferably, the efficacy components comprise the following components in parts by weight: acetyl hexapeptide-81-5 parts, dipeptide diaminobutyrylbenzylamide diacetate 1-5 parts, tight face wrinkle resistant peptide 1-4 parts and oat beta-glucan 1-5 parts;
preferably, the anti-wrinkle and anti-wrinkle peptide comprises sweet almond seed extract and hydrolyzed rice protein;
preferably, the weight ratio of the sweet almond seed extract to the hydrolyzed rice protein is (1.5-2.5) to 1;
preferably, the efficacy component further comprises ON-mediline;
preferably, the weight part of the ON-MEDI LINE is 1-5 parts;
preferably, the ON-mediline comprises centella asiatica extract, polygonum cuspidatum root extract, astragalus membranaceus root extract, tea leaf extract, glycyrrhiza glabra root extract, chamomile flower extract, and rosmarinus officinalis extract;
preferably, the weight ratio of the centella asiatica extract, the polygonum cuspidatum root extract, the astragalus membranaceus root extract, the tea leaf extract, the glycyrrhiza glabra root extract, the chamomile flower extract and the rosewood extract is 1 (0.5-1.5): 0.5-1.5: (0.5-1.5).
3. The wrinkle-removing composition according to claim 1 or 2, wherein the aqueous phase component comprises a moisturizer, a coffee extract and water;
preferably, the water phase component comprises the following components in parts by weight: 1-7 parts of humectant, 0.1-1 part of coffee extract and 65-85 parts of water;
preferably, the humectant comprises any one or a combination of at least two of trehalose, sodium hyaluronate, 1, 2-hexanediol or butanediol, preferably a combination of trehalose, sodium hyaluronate, 1, 2-hexanediol and butanediol;
preferably, the weight ratio of the trehalose to the sodium hyaluronate to the 1, 2-hexanediol to the butanediol is (0.2-2): 0.02-0.2): 0.1-0.5): 1-4;
preferably, the molecular weight of the sodium hyaluronate is 1000-3000 kDa;
preferably, the water comprises deionized water;
preferably, the aqueous phase component further comprises a thickener;
preferably, the weight part of the thickening agent is 0.2-0.6 part;
preferably, the thickener comprises any one or a combination of at least two of carbomer, sodium carboxymethylcellulose or xanthan gum, preferably carbomer.
4. A wrinkle-reducing composition as claimed in any one of claims 1-3, characterized in that the oil phase components comprise an emollient and an emulsifier;
preferably, the oil phase component comprises the following components in parts by weight: 2-13 parts of an emollient and 1-5 parts of an emulsifier;
preferably, the emollient comprises any one or a combination of at least two of dioctyl carbonate, squalane, argan nut oil, or shea butter, preferably a combination of dioctyl carbonate, squalane, argan nut oil, and shea butter;
preferably, the weight ratio of the dioctyl carbonate, the squalane, the argan tree kernel oil and the shea butter is (1-5): (0.1-1): (0.5-2);
preferably, the emulsifier comprises any one or a combination of at least two of Simulsol 165, PolyAquol 2W or TWEEN 80, preferably PolyAquol 2W;
preferably, the PolyAquol 2W comprises polyglycerol-2 stearate, glyceryl stearate and stearic acid;
preferably, the oil phase component further comprises an antioxidant;
preferably, the antioxidant is 0.1-1 part by weight;
preferably, the antioxidant comprises any one or a combination of at least two of tocopheryl acetate, tea polyphenols or glutathione, preferably tocopheryl acetate.
5. The wrinkle-removing composition as claimed in any one of claims 1-4, wherein the raw materials for preparing the wrinkle-removing composition further comprise a pH-adjusting agent;
preferably, the weight portion of the pH regulator is 0.06-0.25;
preferably, the pH adjusting agent comprises any one or a combination of at least two of aminomethyl propanol, triethanolamine or isopropanolamine, preferably aminomethyl propanol;
preferably, the raw materials for preparing the wrinkle-removing composition also comprise a chelating agent;
preferably, the chelating agent is 0.01-0.3 part by weight;
preferably, the chelating agent comprises caprylhydroxamic acid and/or disodium edetate, preferably caprylhydroxamic acid.
6. The wrinkle-removing composition as claimed in any one of claims 1-5, wherein the wrinkle-removing composition is prepared from raw materials comprising an efficacy component, a water phase component, an oil phase component, a pH regulator and a chelating agent;
wherein the functional components comprise the following components in parts by weight: 1-5 parts of oat beta-glucan, 81-5 parts of acetyl hexapeptide, 1-5 parts of dipeptide diaminobutyryl benzylamide diacetate, 1-4 parts of tight face and anti-wrinkle peptide and 1-5 parts of ON-MEDI LINE;
the water phase components comprise the following components in parts by weight: 0.2-2 parts of trehalose, 0.02-0.1 part of sodium hyaluronate, 0.1-0.5 part of 1, 2-hexanediol, 1-4 parts of butanediol, 0.1-1 part of coffee extract, 0.2-0.6 part of carbomer and 65-85 parts of deionized water;
the oil phase comprises the following components in parts by weight: 1-5 parts of dioctyl carbonate, 1-5 parts of squalane, 0.1-1 part of argania spinosa kernel oil, 0.5-2 parts of shea butter, 1-5 parts of Polyaquol 2W and 0.1-1 part of tocopherol acetate;
the pH regulator comprises the following components in parts by weight: 0.06-0.25 part of aminomethyl propanol, wherein the chelating agent comprises the following components in parts by weight: 0.01-0.3 part of caprylyl hydroximic acid.
7. A method of preparing a wrinkle-reducing composition according to any one of claims 1-6, characterised in that the method of preparation comprises the steps of: mixing and stirring functional components containing acetyl hexapeptide-8, dipeptide diaminobutyrylbenzyl amide diacetate and face-tightening anti-wrinkle peptide, a water phase component and an oil phase component to obtain the wrinkle-removing composition;
preferably, the preparation method of the aqueous phase component comprises the following steps: mixing humectant, coffee extract, optional thickener and deionized water, and stirring to obtain water phase component; the humectant comprises any one or a combination of at least two of trehalose, sodium hyaluronate or butanediol;
preferably, in the preparation method of the water phase component, the stirring temperature is 75-85 ℃ and the time is 10-15 min;
preferably, the preparation method of the oil phase component comprises the following steps: mixing and stirring an emollient, an emulsifier and an optional antioxidant to obtain the oil phase component;
preferably, in the preparation method of the oil phase component, the stirring temperature is 75-85 ℃ and the time is 10-15 min.
8. A method of preparing a wrinkle-reducing composition as claimed in claim 7, characterized in that the method of preparing the wrinkle-reducing composition comprises the steps of:
(a) mixing the water phase component and the oil phase component, stirring and homogenizing to obtain a mixture 1;
(b) mixing a pH regulator with the mixture 1 obtained in the step (a), and stirring to obtain a mixture 2;
(c) mixing a chelating agent, optionally 1, 2-hexanediol, and the mixture 2 obtained in step (b), and stirring to obtain a mixture 3;
(d) mixing the functional components with the mixture 3 obtained in the step (c), and stirring to obtain the wrinkle-removing composition;
preferably, in the step (a), the stirring temperature is 75-85 ℃ and the stirring time is 5-10 min;
preferably, in the step (b), the stirring temperature is 60-65 ℃ and the stirring time is 5-10 min;
preferably, in the step (c), the stirring temperature is 50-55 ℃ and the stirring time is 5-10 min;
preferably, in step (d), the stirring temperature is 25-40 ℃ and the time is 10-15 min.
9. A method of preparing a wrinkle-reducing composition as claimed in claim 7 or 8, characterized in that the method comprises the steps of:
(1) mixing humectant, coffee extract, optional thickener and deionized water, stirring at 75-85 deg.C for 10-15min to obtain water phase component, wherein the humectant comprises one or more of trehalose, sodium hyaluronate or butanediol; mixing emollient, emulsifier and optional antioxidant, and stirring at 75-85 deg.C for 10-15min to obtain oil phase component;
(2) mixing the water phase component and the oil phase component obtained in the step (1), stirring for 5-10min at 75-85 ℃, and homogenizing to obtain a mixture 1;
(3) mixing a pH regulator with the mixture 1 obtained in the step (2), and stirring at 60-65 ℃ for 5-10min to obtain a mixture 2;
(4) mixing a chelating agent, optional 1, 2-hexanediol and the mixture 2 obtained in the step (3), and stirring at 50-55 ℃ for 5-10min to obtain a mixture 3;
(5) and (4) mixing the functional components with the mixture 3 obtained in the step (4), and stirring for 10-15min at 25-40 ℃ to obtain the wrinkle-removing composition.
10. Use of a wrinkle-removing composition according to any one of claims 1 to 6 for the preparation of a cosmetic for wrinkle-removing and tightening the eyes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210060301.8A CN114246817A (en) | 2022-01-19 | 2022-01-19 | Wrinkle-removing composition and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210060301.8A CN114246817A (en) | 2022-01-19 | 2022-01-19 | Wrinkle-removing composition and preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114246817A true CN114246817A (en) | 2022-03-29 |
Family
ID=80796662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210060301.8A Pending CN114246817A (en) | 2022-01-19 | 2022-01-19 | Wrinkle-removing composition and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114246817A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113908110A (en) * | 2021-12-01 | 2022-01-11 | 易生彬 | Anti-aging traditional Chinese medicine skin care composition for periocular period and preparation method thereof |
| CN116196236A (en) * | 2023-03-23 | 2023-06-02 | 配方化妆品科技(广州)有限公司 | Hairline toughening agent capable of resisting washing and application thereof |
| CN117257691A (en) * | 2023-11-10 | 2023-12-22 | 花安堂生物科技集团有限公司 | Composition for reducing neck wrinkles, neck mask patch and preparation method thereof |
| CN117942276A (en) * | 2024-03-27 | 2024-04-30 | 南京斯拜科生物科技股份有限公司 | Compound peptide for realizing percutaneous absorption promotion of fibroblast proliferation under low concentration and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100215726A1 (en) * | 2009-02-25 | 2010-08-26 | Peter Thomas Roth | Compositions for Diminishing the Appearance of Wrinkles |
| CN110613676A (en) * | 2019-11-01 | 2019-12-27 | 深圳美丽魔方健康科技有限公司 | Chitosan marine peptide crystal facial mask |
| KR20200020623A (en) * | 2018-08-16 | 2020-02-26 | 주식회사 펠리즈코스 | Composition for enhancing skin condition having skin regeneration and anti-inflammation effect |
| CN111228208A (en) * | 2020-02-26 | 2020-06-05 | 广州留今科学研究有限公司 | Wrinkle-removing composition containing symbiotic bacteria combined fermentation product, wrinkle-removing eye cream and preparation method of wrinkle-removing eye cream |
| CN113648272A (en) * | 2021-08-26 | 2021-11-16 | 华侨大学 | A kind of moisturizing and wrinkle-removing eye cream and preparation method thereof |
-
2022
- 2022-01-19 CN CN202210060301.8A patent/CN114246817A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100215726A1 (en) * | 2009-02-25 | 2010-08-26 | Peter Thomas Roth | Compositions for Diminishing the Appearance of Wrinkles |
| KR20200020623A (en) * | 2018-08-16 | 2020-02-26 | 주식회사 펠리즈코스 | Composition for enhancing skin condition having skin regeneration and anti-inflammation effect |
| CN110613676A (en) * | 2019-11-01 | 2019-12-27 | 深圳美丽魔方健康科技有限公司 | Chitosan marine peptide crystal facial mask |
| CN111228208A (en) * | 2020-02-26 | 2020-06-05 | 广州留今科学研究有限公司 | Wrinkle-removing composition containing symbiotic bacteria combined fermentation product, wrinkle-removing eye cream and preparation method of wrinkle-removing eye cream |
| CN113648272A (en) * | 2021-08-26 | 2021-11-16 | 华侨大学 | A kind of moisturizing and wrinkle-removing eye cream and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 欧春凤;许晓华;万阳;徐晶;夏晓初;马义;: "复合多肽眼霜的延缓衰老功效测试与分析", 日用化学工业 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113908110A (en) * | 2021-12-01 | 2022-01-11 | 易生彬 | Anti-aging traditional Chinese medicine skin care composition for periocular period and preparation method thereof |
| CN116196236A (en) * | 2023-03-23 | 2023-06-02 | 配方化妆品科技(广州)有限公司 | Hairline toughening agent capable of resisting washing and application thereof |
| CN116196236B (en) * | 2023-03-23 | 2023-09-19 | 配方化妆品科技(广州)有限公司 | Hairline toughening agent capable of resisting washing and application thereof |
| CN117257691A (en) * | 2023-11-10 | 2023-12-22 | 花安堂生物科技集团有限公司 | Composition for reducing neck wrinkles, neck mask patch and preparation method thereof |
| CN117942276A (en) * | 2024-03-27 | 2024-04-30 | 南京斯拜科生物科技股份有限公司 | Compound peptide for realizing percutaneous absorption promotion of fibroblast proliferation under low concentration and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111249209B (en) | Moisturizing repair cream and preparation method thereof | |
| CN103237555B (en) | Topical skin care formulation | |
| CN114246817A (en) | Wrinkle-removing composition and preparation method and application thereof | |
| CN102711721B (en) | Skin care formulations | |
| CN112494406A (en) | Whitening and freckle-removing cosmetic and preparation method thereof | |
| CN109288764B (en) | Hydrolat spray and preparation method thereof | |
| CN110638709A (en) | Anti-blue-light multi-effect repair eye cream and preparation method thereof | |
| CN109363998B (en) | Whitening cosmetic additive, whitening essence stock solution and preparation method thereof | |
| CN109453087B (en) | Whitening skin-penetrating lotion, preparation method thereof and whitening cosmetic additive | |
| CN110691630A (en) | Use of extract of rambutan peel for moisturizing skin and/or mucous membranes | |
| KR20110057895A (en) | Skin external preparation composition for promoting hyaluronic acid production containing ginsenoside R and ginsenoside compound VII | |
| CN116712370B (en) | A mild cosmetic composition with whitening and moisturizing effects and preparation method thereof | |
| CN112294739A (en) | Multi-effect whitening composition and application thereof in moisturizer | |
| CN114306165A (en) | Moisturizing composition and preparation method thereof | |
| KR101114161B1 (en) | Body Detergent composition for moisturizing or soothing the skin containing Aloe barbadensis miller extract and Althaea officinalis root extract | |
| CN113368003A (en) | Composition with overnight muscle repairing effect and preparation method and application thereof | |
| CN116459169B (en) | Anti-inflammatory moisturizing skin external composition and preparation method and application thereof | |
| CN108703917B (en) | Anti-aging composition and cosmetic prepared from same | |
| CN114073645A (en) | A skin care composition containing mineral components and its preparation method | |
| CN116869912A (en) | Photodamage repair essence and preparation method thereof | |
| CN110368325B (en) | A kind of anti-wrinkle composition and its preparation method and application | |
| CN115919686A (en) | Skin soothing lotion for enhancing skin barrier and preparation method thereof | |
| CN115040448A (en) | Skin care product with enhanced anti-aging effect and preparation method thereof | |
| CN114288201A (en) | Composition for removing under-eye puffiness and fading black eye circles and preparation method and application thereof | |
| CN113384483A (en) | Composition for improving skin elasticity and delaying aging and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220329 |